Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ADPT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ADPT investment potential.

What is ADPT stock price today?

Get real-time ADPT stock price, historical data, and price charts on Financhill. Track ADPT performance with our advanced analysis tools.

Is ADPT a good investment?

Evaluate ADPT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ADPT stock?

To buy ADPT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ADPT?

View detailed market capitalization data and company valuation metrics for ADPT on our comprehensive analysis page.

What is the P/E ratio of ADPT?

Use our fundamental analysis tools to view ADPT P/E ratio and compare valuation metrics with industry peers.

What are ADPT earnings?

View ADPT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Adaptive Biotechnologies Corp. Stock Predictions

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

ADPT
Adaptive Biotechnologies Corp.

Last Price:

$16.69

Seasonality Move:

-17.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

Adaptive Biotechnologies Corp. Stock Forecast

Over the next 52 weeks, Adaptive Biotechnologies Corp. has on average historically risen by 16.9% based on the past 6 years of stock performance.
Adaptive Biotechnologies Corp. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Adaptive Biotechnologies Corp. Stock Undervalued?

The current Adaptive Biotechnologies Corp. [ADPT] share price is $16.12. The Score for ADPT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
ADPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Adaptive Biotechnologies Corp. Stock Go Up Next Year?

Over the next 52 weeks, Adaptive Biotechnologies Corp. has on average historically risen by 16.9% based on the past 6 years of stock performance.

Adaptive Biotechnologies Corp. Stock Rating

Buy

Adaptive Biotechnologies Corp. (ADPT) is a Buy

Is Adaptive Biotechnologies Corp. overpriced?

Adaptive Biotechnologies Corp. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Adaptive Biotechnologies Corp. Stock Price History

Is ADPT stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADPT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Life Sciences Tools & Services

Sector:

Health Care

Type:

stock

Website:

adaptivebiotech.com

52-Week Data

52-Week High:

20.76

52-Week Low:

5.81

Prediction Charts

Market Cap:

2.5B

Price in USD:

16.12

Volume:

2.4M

Beta:

1.51

Technical Analysis

SMA50:

16.44

SMA100:

14.62

SMA200:

11.93

52-Wk Change:

147.24%

Stock Predictions

Is Adaptive Biotechnologies Corp. stock public?

Yes, Adaptive Biotechnologies Corp. is a publicly traded company.
What is the Adaptive Biotechnologies Corp. stock quote today?

The Adaptive Biotechnologies Corp. stock price is 16.12 USD today.
How to buy Adaptive Biotechnologies Corp. stock online?

You can buy Adaptive Biotechnologies Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-28	19.72	19.66	19.72	19.25
Dec-1	19.26	18.84	19.31	18.59
Dec-2	18.84	18.69	19.27	18.52
Dec-3	18.87	17.13	18.87	16.50
Dec-4	16.86	17.46	17.58	16.45
Dec-5	16.24	14.75	16.25	14.65
Dec-8	14.71	14.95	15.24	14.58
Dec-9	14.74	14.86	15.62	14.69
Dec-10	14.93	15.74	16.26	14.91
Dec-11	15.74	15.42	16.07	14.94
Dec-12	15.38	15.44	15.53	15.11
Dec-15	16.03	15.69	16.08	15.35
Dec-16	15.66	15.93	16.06	15.50
Dec-17	15.78	16.12	16.48	15.60

Adaptive Biotechnologies Corp. Earnings

Adaptive Biotechnologies Corp. Earnings Report: Per Share Adaptive Biotechnologies Corp. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Adaptive Biotechnologies Corp. Forecast Revenue Growth

Adaptive Biotechnologies Corp. Stock Analysis: Historical quarterly revenues per share for Adaptive Biotechnologies Corp. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and a decrease next year of $0.09 per share.

* Adaptive Biotechnologies Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.